US FDA approves Citius therapy to treat rare blood cancer
The U.S. Food and Drug Administration has approved a drug Citius Pharmaceuticals company said Thursday is a therapy for patients with a form of blood cancer who have already undergone at least one course of treatment, a year after the regulator rejected it.
BELIEBTE BEITRÄGE
Poland prepares for peaking floods
September 20, 2024
Italy evacuates thousands as Boris hits the north
September 20, 2024
China and the US race to tame nuclear fusion for clean energy
September 20, 2024
LIVEÜBERTRAGUNG